Inhibitory effect of n-butanol fraction of Moringa oleifera Lam. seeds on ovalbumin-induced airway inflammation in a guinea pig model of asthma

International Journal of Toxicology

Volumn 28, Issue 6, 2009, Pages 519-527

  Mahajan, Shailaja G ^a   Banerjee, Aryamitra ^b   Chauhan, Bhupendrasinh F ^b   Padh, Harish ^b   Nivsarkar, Manish ^b   Mehta, Anita A ^a  

^a L M COLLEGE OF PHARMACY   (India)

^b B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

Author keywords

Asthma; Cytokines; Moringa oleifera; Ovalbumin

Indexed keywords

ACETYLCHOLINE; ALKALOID; BUTANOL; DEXAMETHASONE; FLAVONOID; GLYCOSIDE; HISTAMINE; INTERLEUKIN 4; INTERLEUKIN 6; MORINGA OLEIFERA EXTRACT; OVALBUMIN; POLYPHENOL; SAPONIN; STEROID; TANNIN; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BLOOD ANALYSIS; BODY WEIGHT; BREATHING RATE; BRONCHOSPASM; CELL COUNT; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL GUINEA PIG; FEMALE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NONHUMAN; PARAMETER; PHYTOCHEMISTRY; PLANT SEED; PROTEIN DETERMINATION; RESPIRATORY TRACT INFLAMMATION; TH1 CELL; TH2 CELL; TIDAL VOLUME; TISSUE HOMOGENATE;

1-BUTANOL; ACETYLCHOLINE; ANIMALS; ASTHMA; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; CELL COUNT; CYTOKINES; FEMALE; GUINEA PIGS; HISTAMINE; HISTAMINE RELEASE; INFLAMMATION; LUNG; MALE; MORINGA OLEIFERA; OVALBUMIN; PHYTOTHERAPY; PLANT EXTRACTS; RESPIRATORY FUNCTION TESTS; SEEDS; SERINE PROTEINASE INHIBITORS; SOLVENTS;

ANIMALIA; CAVIA; MORINGA OLEIFERA; MORINGACEAE;

EID: 73549092718     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581809345165     Document Type: Article

References (55)

1. Hattori T, Hizawa N, Takahashi D, et al. Total serum IgE levels in eosinophilic lung diseases. Arerugi. 2006;55:647-654.
2. Godard P, Bourdin A, Chanez P. Assessment of quality of care in asthma. Rev Mal Respir. 2007;24:197-204.
3. Saria A, Lundberg MJ, Skoftsch G, Lembeck F. Vascular protein leakage in various tissues is induced by substance P, capsaicin, bradykinin, serotonin, histamine, and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol. 1983;324:212-218.
4. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis. 1988;137:62-69.
5. Sur S, Crotty TB, Kephart GM. Sudden onset fatal asthma: a distinct clinical entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993; 148:713-719.
6. Romagnani S. The role of lymphocytes in allergic diseases. J Allergy Clin Immunol. 2000;105:399-408.
7. Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator and permeability changes. Am Rev Respir Dis. 1991;144:51-58.
8. Chung KF, Barnes PJ. Cytokines in asthma. Thorax. 1999;54: 825-857.
9. Wenzel SE, Szefler SJ, Leung DY. Bronchoscopic evaluation of severe asthma. Am J Respir Crit Care M Ed. 1997;156:737-743.
10. Ind PW, Barnes PJ, Brown MJ, Causen R, Dollery CT. Measurement of plasma histamine. Clin Allergy. 1983;13:61-67.
11. Irie M, Nagata S, Endo Y. Effect of isolation on classical conditioned histamine release in guinea pigs. Neurosci Res. 2002; 44:31-35.
12. Bartosch H, Feldberg W, Nagel E. Das Freiwerden eines histaminahnlichen stoffes bei der anaphylaxie der Meerschwein chens. Pflugers Arch Ges Physiol. 1932;230:120-153.
13. Broide DH, Lotz M, Cuomo AJ, et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992;89:958-967.
14. Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J. 1998;11:1218-1221.
15. Gharaee-Kermani M, Nozaki Y, Hatano K, Phan SH. Lung interleukin-4 gene expression in a murine model of bleomycininduced pulmonary fibrosis. Cytokines. 2001;15:138-147.
16. Elias JA, Wu Y, Zheng T, Panettieri R. Cytokine and virusstimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol. 1997;273:L648-L655.
17. Wennergren G. Inflammatory mediators in blood and urine. Paediatr Respir Rev. 2003;1:259-265.
18. Mughal MH, Ali G, Srivastava PS, Iqbal M. Improvement of drumstick (Moringa pterygosperms Gaertn.) a unique source of food and medicine through tissue culture. Hamdard M Ed. 1994;2:37-42.
19. Rajan BK. Apiculture and farm forestry in semi-acid tracts of Karnataka. My Forest. 1986;22:41-49.
20. Faizi S, Siddiqui BS, Saleem R, et al. Fully acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry (Oxford). 1995;38:957-963.
21. Varier VP. Indian Medicinal Plants Compendium of 500 Species. Vol 4. Warrier PK, Nambiar V, Ramankutty C, eds. Madras, India: Orient Longman; 1997:58-62.
22. Mahajan SG, Mali RG, Mehta AA. Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats. J Immunotoxicol. 2007a;4:39-47.
23. Guevara AP, Vargas C, Sakurai H, et al. An antitumor promoter from Moringa oleifera Lam. Mutat Res. 1999;440:181-188.
24. Chopra RN, Chopra IC, Handa K, Kapur D. Chopra's Indigenous drugs of India. Calcutta, India: Dhur; 1938.
25. Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed, Vol 1. In: Dun D, Singh B, Singh MP, eds. New Cannaught Place-Dehradun, India: M/s Bishen Singh Mahendra Pal Singh;1975: 676-683.
26. Agrawal B, Mehta A. Antiasthmatic activity of Moringa oleifera Lam: a clinical study. Indian J Pharmacol. 2008;40:20-31.
27. Agrawal BB, Mehta AA. A preliminary clinical study on Moringa oleifera Lam. in bronchial asthmatic patients. Planta Ind. 2006;2: 51-54.
28. Mahajan SG, Mali RG, Mehta AA. Effect of Moringa oleifera Lam. seed extract on toluene diisocyanate-induced immunemedicated inflammatory responses in rats. J Immunotoxicol. 2007b;4:85-96.
29. Mahajan SG, Mehta AA. Effect of Moringa oleifera Lam. seed extract on ovalbumin induced airway inflammation in guinea pigs. Inhalation Toxicol. 2008;20:897-909.
30. Ogunbiyi PO, Eyre P. Pharmacological studies of pulmonary anaphylaxis in vitro. Agents Action. 1985;17:158-173.
31. Paech D, Tracey MV, eds. Modern Methods of Plant Analysis. Vol IV. Berlin, Germany: Springer-Verlag;1955:373-374.
32. Duan W, Kua IC, Selvarajan S, et al. Anti-inflammatory effects of genistein, a tyrosine kinase inhibitor, on guinea pig model of asthma. Am J Respir Crit Care M Ed. 2003;167:185-192.
33. Shore PA, Burkhalter A, Cohn VH. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959;127: 182-186.
34. Chung KF, Adcock I. Application of cell and molecular biology techniques to unravel causes and pathophysiological mechanisms. In: Chung KF, Adcock I, eds. Asthma Mechanisms and Protocols. Totowa, NJ: Humana Press; 2000:1-29.
35. Ziment I. Alternative therapies for asthma. Curr Opin Pulm M Ed. 1997;3:61-71.
36. Zhang JC. Preliminary report on the serum level of pancreatic polypeptide in patients with chronic bronchitis and bronchial asthma during attacks. Zhonghua Jie He He Hu Xi Za Zhi. 1989;12:141-142.
37. Govindan S, Viswanathan S, Vijavasekaran V, Alagappan R. Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytother Res. 2004; 18:805-809.
38. Kaik KG, Witte PU. Protective effect of forskolin in acetylcholine provocation in healthy probands: comparison doses with fenoterol and placebo. Wein Med Wochenshr. 1986;136:637-641.
39. Pretolani M, Ruffie C, Joseph D, et al. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am J Respir Crit Care M Ed. 1994;149:1167-1174.
40. Gundel RH, Wagner CD, Letts G. The onset and recovery from hyperresponsiveness: relationship with inflammatory cell infiltrates and release of cytotoxic granule proteins. Clin Exp Allergy. 1992;22:303-308.
41. Ricci M, Matucci A, Rossi O. New advances in the pathogenesis and therapy of bronchial asthma. Ann Ital Med Int. 1998;13:93-110.
42. Bradding P, Roberts JA, Britten KM, et al. Interleukins-4,-5 and-6, and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994;10:471-480.
43. Theoharidesa TC, Cochraned DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol. 2004;146:1-12.
44. Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES. Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am J Respir Crit Care M Ed. 1994;149:1506-1511.
45. Singh R, Bhattacharya KSK, Acharya SB. Studies on extracts of Elaeocarpus sphaericus fruits on in vitro rat mast cells. Phytomedicine. 2000;7:205-207.
46. Christofidou-Solomidou M, Muzykantov VR. Antioxidant strategies in respiratory medicine. Treat Respir M Ed. 2006;5:47-78.
47. Mascolo N, Pinto A, Capasso F. Flavonoids, leucocyte migration, and eicosanoids. J Pharm Pharmacol. 1988;40:293-295.
48. Dorsch W, Adam O, Weber J, Ziegeltrum T. Antiasthmatic effects of onion extracts-detection of benzyl and other isothiocyanates (mustard oils) as antiasthmatic compounds of plant origin. Eur J Pharmacol. 1984;107:17-24.
49. Yuk JE, Woo JS, Yun CY, et al. Effects of lactose-β-sitosterol and β-sitosterol on ovalbumin-induced lung inflammation in actively sensitized mice. Int Immunopharmacol. 2007;7:1517-1527.
50. Laandrault N, Pouchert P, Ravel P, et al. Antioxidant activities phenolic level of French wines from different varieties and vintages. J Agric Food Chem. 2001;49:3341-3343.
51. Memon GM, Memon SA, Memon AR. Isolation and structure elucidation of moringyne, a new glycoside from the seeds of M. oleifera. Pak J Sci Ind Res. 1985;28:7-9.
52. Villasenor IM. Bioactive metabolites from Moringa oleifera Lam. Kimika. 1994;110:47-52.
53. Dayrit FM, Alcantara AD, Villaseñor I. The antibiotic compound and its deactivation in aqueous solution. Phil J Sci. 1990;119: 23-26.
54. Njoku OU, Adikwu MU. Investigation on some physicochemical antioxidant and toxicological properties of Moringa oleifera seed oil. Acta. Pharma Zagr. 1997;47:287-290.
55. Dahot MU, Memon AR. Nutritive significance of oil extracted from Moringa oleifera seeds. J Pharm Univ Karachi. 1985;3: 75-80.